Through strong industry cooperation, significant investment, and smart policy backing, API manufacturing may become self-reliant
The European regulator will conduct a re-inspection of the facility to verify the compliance
This is Senores' second API manufacturing facility adding significantly to the existing API manufacturing capabilities.
USFDA inspection at Emcure Pharmaceuticals API facility
This facility is considered to be in a minimally acceptable state of compliance with regard to current GMP
FDC Ltd has received final approval from USFDA for the company's Abbreviated New Drug Application (ANDA) for Cefixime 400 mg Tablets
The company will receive GMP compliance certificate which will further help to accelerate the business growth across the globe
Jagsonpal Pharmaceuticals has received full consideration of Rs. 41 crore towards the sale of the facility and will now be proceeding with registration formalities
EBITDA for the quarter is Rs. 21.6 crore as against Rs. 18.1 crore in Q2 FY24
The company reported a net profit of Rs 46.15 crore in Q2 FY25 as compared to Rs 23.88 crore in Q2 FY24
Subscribe To Our Newsletter & Stay Updated
